M1 macrophage-engineered vesicles have anti-cancer activity in ovarian cancer

M1 macrophage-engineered vesicles have anti-cancer activity in ovarian cancer

Abstract Background Ovarian cancer typically presents at an advanced stage, has a poor prognosis, and is a leading cause of cancer-related deaths in women. Extracellular vesicles (EVs) are cell membrane-derived nanoparticles that function in specific cell-to-cell communication and are under developm...

Full description

Saved in:
Bibliographic Details
Main Authors: Connie D. Cao, J. Robert McCorkle, Derek B. Allison, Donglin Yan, Kristen S. Hill, Lan Li, Rani Jayswal, David Schweer, Charles S. Dietrich, Frederick R. Ueland, Christopher I. Richards, Jill M. Kolesar
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Cancer Nanotechnology
Subjects:
Ovarian cancer
Extracellular vesicles
Engineered vesicles
Immunotherapy
Online Access:https://doi.org/10.1186/s12645-025-00337-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12645-025-00337-y

Similar Items